Volume 31, Number 1 (spring 2007)                   Research in Medicine 2007, 31(1): 61-65 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ozgoli G, Goli M, Moattar F, Valaie N. Comparing ginger with mefenamic acid and ibubrofen for the treatment of primary dysmenorrhea. Research in Medicine. 2007; 31 (1) :61-65
URL: http://pejouhesh.sbmu.ac.ir/article-1-357-en.html

, gozgoli@yahoo.com
Abstract:   (26144 Views)
Background: Primary dysmenorrhea is a frequent entity with known side effects on life quality. Ginger has been shown to inhibit prostaglandins, thus, the present study was designed to compare ginger with mefenamic acid and ibubrofen for the treatment of primary dysmenorrhea in a group of students in dormitories affiliated to Isfahan and Shahid Beheshti University of Medical Sciences. Materials and methods: For this double-blinded clinical trial, 150 students with primary dysmenorrhea were enrolled. Subjects were matched according to dysmenorrheal severity, then, assigned in 3 equal groups of ginger (250mg), mefenamic acid (250mg), and ibubrofen (400mg) that were all prescribed 4 times a day for 3 days. Groups were matched according to the following criteria: age, age of menarche onset, weight, height, BMI, father’s position, maternal occupation and level of education, regular exercise, and duration, interval and amount of menses’ bleeding. Finally, verbal multidimensional scoring system was used to assess the efficacy of drugs on dysmenorrhea. ANOVA and chi square were used for data analysis. Results: Dysmenorrheal improvement did not differ significantly among ginger (64%), mefenamic acid (58%) and ibubrofen (66%) groups. Thus, ginger is as effective as mefenamic acid and ibubrofen in alleviating dysmenorrheal symptoms. Conclusion: Ginger is an effective drug for alleviating primary dysmenorrheal symptoms.
Full-Text [PDF 174 kb]   (3374 Downloads)    
Type of Study: Original | Subject: General
Received: 2007/10/21

Send email to the article author


Creative Commons License
This Journal is licensed under a Creative Commons Attribution 4.0 International License  | Research in Medicine

Designed & Developed by : Yektaweb